Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

INSANE: Eiger - The Real Truth

Recap of Wednesday's Biotech Catalysts - End of The Day Summary

Benzinga · Jul 20, 2022

EMA's Advisory Committee Recommends Eiger's Zokinvy In Premature Aging Disorder

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending Eiger BioPharmaceuticals Inc's (NASDAQ:EIGR) Zokinvy for Hutchinson-Gilford progeria syndrome (HGPS) and processing-deficient progeroid laminopathies (PL). HGPS and PL are ultra-rare and fatal pediatric diseases that cause dramatically accelerated aging and premature death. The CHMP…

Benzinga · May 20, 2022

The Daily Biotech Pulse: Veru Shares Up On COVID Candidate Update, FDA Approves Lilly's COVID Treatment, Latest On Sanofi-AstraZeneca RSV Vaccine

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga · May 11, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Why Eiger BioPharmaceuticals Stock Is Jumping Today

Eiger BioPharmaceuticals Inc (NASDAQ: EIGR) announced data from the Phase 3 TOGETHER study evaluating Peginterferon Lambda in non-hospitalized COVID-19 adult patients at high risk of progressing to severe illness.

Benzinga · Mar 17, 2022

Coverage From

Benzinga

People

Hutchinson

38 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

European Medicines Agency

77 stories

Lambda

32 stories

Rhythm Pharmaceuticals

Ionis Pharmaceuticals

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.